147 related articles for article (PubMed ID: 31028202)
21. EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer.
Satoh Y; Matsuo Y; Kuba T; Yamashita K; Sawano M; Tozaka S; Yamazaki H; Sonoda D; Mikubo M; Naito M; Matsui Y; Shiomi K; Yoshida T; Murakumo Y
Virchows Arch; 2020 May; 476(5):753-762. PubMed ID: 31823000
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
Wang Z; Huang C; Zhang A; Lu C; Liu L
Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
[TBL] [Abstract][Full Text] [Related]
23. Epidermal Growth Factor Receptor (EGFR) Mutations and Anaplastic Lymphoma Kinase/Oncogene or C-Ros Oncogene 1 (ALK/ROS1) Fusions Inflict Non-Small Cell Lung Cancer (NSCLC) Female Patients Older Than 60 Years of Age.
Ke L; Xu M; Jiang X; Sun X
Med Sci Monit; 2018 Dec; 24():9364-9369. PubMed ID: 30580372
[TBL] [Abstract][Full Text] [Related]
24. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
Byeon S; Lee B; Park WY; Choi YL; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
Clin Lung Cancer; 2020 May; 21(3):e182-e190. PubMed ID: 31839532
[TBL] [Abstract][Full Text] [Related]
25. Impact of EGFR Mutation and ALK Translocation on Recurrence Pattern After Definitive Chemoradiotherapy for Inoperable Stage III Non-squamous Non-small-cell Lung Cancer.
Nakamura M; Kageyama SI; Niho S; Okumura M; Hojo H; Motegi A; Nakamura N; Zenda S; Yoh K; Goto K; Akimoto T
Clin Lung Cancer; 2019 May; 20(3):e256-e264. PubMed ID: 30926356
[TBL] [Abstract][Full Text] [Related]
26. SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy.
Ji X; Liu Y; Mei F; Li X; Zhang M; Yao B; Wu R; You J; Pei F
Sci Rep; 2021 Jul; 11(1):14031. PubMed ID: 34234236
[TBL] [Abstract][Full Text] [Related]
27. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
[TBL] [Abstract][Full Text] [Related]
28. ALK Protein Expression Patterns in Squamous Cell Carcinoma of the Oral Cavity.
Chrysovergis A; Papanikolaou V; Mastronikolis N; Tsiambas E; Katsinis S; Manoli A; Papouliakos S; Ragos V; Pantos P; Peschos D; Mastronikolis S; Fotiades P; Mamoulidis P; Spyropoulou D; Kyrodimos E
In Vivo; 2022; 36(3):1144-1149. PubMed ID: 35478149
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.
Pan C; Du Z; Cai Z; Liu Y; Sun Y; Chen J; Tong T; Chen Q; Zhou L; Bing D; Tao Y; Chu H
Mol Med Rep; 2017 Oct; 16(4):4934-4940. PubMed ID: 28791393
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of peroxiredoxin 3 in laryngeal squamous cell carcinoma.
Zhang H; Liu X; Chen L; Cai L; Li N; Zhu P; Chen J; Song X; Li G
Oncotarget; 2017 Jan; 8(2):3471-3480. PubMed ID: 27966448
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.
Camidge DR; Kono SA; Lu X; Okuyama S; Barón AE; Oton AB; Davies AM; Varella-Garcia M; Franklin W; Doebele RC
J Thorac Oncol; 2011 Apr; 6(4):774-80. PubMed ID: 21336183
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma.
Papanikolaou V; Chrysovergis A; Mastronikolis N; Tsiambas E; Ragos V; Peschos D; Stavraka C; Roukas D; Kyrodimos E
Anticancer Res; 2020 Feb; 40(2):807-811. PubMed ID: 32014923
[TBL] [Abstract][Full Text] [Related]
33. Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis.
Wang S; Ma P; Ma G; Lv Z; Wu F; Guo M; Li Y; Tan Q; Song S; Zhou E; Geng W; Duan Y; Li Y; Jin Y
Eur J Cancer; 2020 Jan; 124():1-14. PubMed ID: 31707279
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma.
Kontić M; Milovanović J; Čolović Z; Poljak NK; Šundov Ž; Sučić A; Pešutić-Pisac V
Eur Arch Otorhinolaryngol; 2015 Feb; 272(2):401-5. PubMed ID: 25294054
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx.
Fujii S; Uryu H; Akashi K; Suzuki K; Yamazaki M; Tahara M; Hayashi R; Ochiai A
Int J Clin Oncol; 2013 Jun; 18(3):454-63. PubMed ID: 22441881
[TBL] [Abstract][Full Text] [Related]
37. Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.
Mao Y; Zhang DW; Lin H; Xiong L; Liu Y; Li QD; Ma J; Cao Q; Chen RJ; Zhu J; Feng ZQ
J Exp Clin Cancer Res; 2012 Dec; 31(1):101. PubMed ID: 23231769
[TBL] [Abstract][Full Text] [Related]
38. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
39. Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma.
Chrysovergis A; Papanikolaou VS; Tsiambas E; Ragos V; Peschos D; Kyrodimos E
Anticancer Res; 2019 Mar; 39(3):1253-1257. PubMed ID: 30842155
[TBL] [Abstract][Full Text] [Related]
40. miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma.
Gao C; Hu S
Cancer Biol Ther; 2019; 20(6):826-836. PubMed ID: 30907227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
